NASDAQ: NTLA       Intellia Thera CS
Last Price Today's Change   Day's Range   Trading Volume
22.905   +0.575 (2.58%)  20.50 - 23.32  454,480


Avg Volume (4 weeks):1,345,878
4 Weeks Range:12.51 - 23.32
4 Weeks Price Volatility (%):
52 Weeks Range:9.18 - 23.32
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Intellia Therapeutics Inc was incorporated in Delaware in May 2014, as AZRN, Inc. In July 2014, the Company changed its name from AZRN, Inc to Interllia Therapeutics Inc. It is a gene editing company focused on the development of proprietary, potentially curative therapeutics utilizing a biological tool known as the CRISPR/Cas9 system. CRISPR/Cas systems include one or more proteins that cleave DNA guided by an RNA guide sequence, pieces of RNA that both recognize specific DNA sequences and activate the cleaving activity of the Cas proteins. The Company's competitors include CRISPR Therapeutics, Inc, Cellectis S.A., Cellectis S.A., and Juno Therapeutics, Inc.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

2956  2620  471  2908 

Top 10 Active Counters
 CIDM 5.975+4.665 
 AVP 5.60-0.05 
 VISL 0.87+0.445 
 GNUS 11.43+3.50 
 AABA 19.630.00 
 NIO 5.765+0.165 
 XSPA 1.98+0.90 
 TGE 22.39+0.81 
 AKRX 0.09-0.094 
 APY 10.34+0.25 
Partners & Brokers